TipRanks
Go Ultimate55% OFF

Quantum Cyber (QUCY) AI Stock Analysis

Top Page

QUCY

Quantum Cyber

(NASDAQ:QUCY)

Select Model
Rating:41Neutral
Price Target:$0.80â–¼(-4.52% Downside)
Action:reiterated
Date:10/16/26

The score is held down primarily by weak financial performance—persistent losses, continued cash burn, and a deteriorating equity cushion—alongside bearish technical signals with the stock trading below key moving averages. Corporate developments are somewhat positive but are tempered by dilution risk from the new ATM program, while valuation metrics offer limited support due to a negative P/E and no dividend yield provided.

Positive Factors
Improving Gross MarginThe substantial gross-margin improvement indicates materially better unit economics over time. If maintained, higher gross profitability can provide more contribution toward operating expenses, support investment in product development, and improve the company’s ability to convert future revenue growth into sustainable earnings.
Negative Factors
Persistent UnprofitabilityPersistent, sizeable operating and net losses show that improved gross profitability has not yet translated into a viable earnings model. Continued losses can consume financial resources, limit internally funded investment, and make the company more dependent on external capital while revenue remains inconsistent.

Quantum Cyber (QUCY) vs. SPDR S&P 500 ETF (SPY)

-100%-50%0%50%100%150%200%QUCY-39.57%SPY+11.79%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
$19.12M
Dividend Yield
―
Average Volume (3M)
652.04K
Price to Earnings (P/E)
-0.4
Beta (1Y)
1.70
Revenue Growth
―
EPS Growth
―
Country
US
Employees
13
Sector
Healthcare
Sector Strength
51
Industry
Medical - Diagnostics & Research

Quantum Cyber Business Overview & Revenue Model

Company Description

Quantum Cyber N.V. operates as a technology company focused on cybersecurity and quantum computing solutions. The company pursues acquisitions and partnerships in areas including post-quantum cryptography, zero-trust architecture, and national securi...

Quantum Cyber Financial Statement Overview

Summary

Despite meaningful gross margin improvement over time, the business remains dominated by persistent large operating/net losses, substantial ongoing cash burn (negative operating and free cash flow each year), and a weakening balance sheet with sharply higher debt-to-equity as equity has fallen—raising near-term financial risk.

Income Statement

18Very Negative

Balance Sheet

24Negative

Cash Flow

15Very Negative
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue250.36K537.08K893.99K895.48K529.88K577.35K
Gross Profit200.20K389.79K574.88K509.66K182.15K177.62K
EBITDA-13.31M-15.22M-19.56M-24.87M-25.72M-11.28M
Net Income-23.96M-16.21M-21.65M-26.30M-26.39M-11.69M
Balance Sheet
Total Assets23.37M5.33M13.50M15.41M20.24M10.04M
Cash, Cash Equivalents and Short-Term Investments13.38M889.09K6.24M7.07M17.14M8.73M
Total Debt168.67K2.57M3.50M7.42M3.23M2.58M
Total Liabilities3.00M4.69M7.50M12.16M6.14M3.68M
Stockholders Equity20.36M641.60K6.00M3.25M14.10M6.36M
Cash Flow
Free Cash Flow-14.50M-12.03M-17.34M-23.84M-15.43M-3.24M
Operating Cash Flow-14.36M-10.98M-17.09M-21.94M-14.77M-3.22M
Investing Cash Flow-319.74K-1.03M-198.82K-1.90M-658.48K1.20M
Financing Cash Flow26.32M6.76M16.60M14.23M23.94M10.61M

Quantum Cyber Technical Analysis

Technical Analysis SentimentNegative
Last Price0.84

Price Trends

50DMA1.27Negative
100DMA1.34Negative
200DMA1.21Negative

Market Momentum

MACD-0.11Positive
RSI32.57Neutral
STOCH22.78Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For QUCY, the sentiment is Negative. The current price of 0.84 is below the 20-day moving average (MA) of 1.09, below the 50-day MA of 1.27, and below the 200-day MA of 1.21, indicating a bearish trend. The MACD of -0.11 indicates Positive momentum. The RSI at 32.57 is Neutral, neither overbought nor oversold. The STOCH value of 22.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for QUCY.

Quantum Cyber Risk Analysis

Quantum Cyber disclosed 40 risk factors in its most recent earnings report. Quantum Cyber reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

2 New Risks
1.Nasdaq maintains certain standards which Nasdaq requires listed companies meet for their respective securities to continue to be listed and traded on its exchange, and if we are unable to continue to meet such continued listing requirements, Nasdaq may choose to delist our ordinary shares from its exchange, which may adversely affect the liquidity and trading price of our ordinary shares.Q4, 2023
2.We are subject to cybersecurity risks to operational systems, security systems, infrastructure and personal data processed by us or third-party vendors or suppliers and any material failure, weakness, interruption, cyber event, incident or breach of security could prevent us from effectively operating our business or subject us to liability for mishandling sensitive data.Q4, 2023

Quantum Cyber Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

QUCY against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
INBSINBS45Neutral$5.84M-0.19-170.36%―38.09%54.22%
QUCYQUCY41Neutral$73.26M-0.45-365.38%―――
ISPCISPC41Neutral$2.08M-0.02-524.37%―-92.11%86.78%
NDRANDRA34Underperform$7.12M-0.75-224.80%――98.17%

* Healthcare Sector Average

Performance Comparison

-50%0%50%100%QUCYNDRAINBSISPCBGLCDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
QUCY and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
QUCYQuantum Cyber N.V.0.84-0.62-42.47%
NDRAEndra Life Sciences4.75-0.42-8.12%
INBSIntelligent Bio Solutions Inc.1.76-7.52-81.03%
ISPCIspecimen Inc0.82-29.16-97.25%
BGLCBionexus Gene Lab Corporation0.92-4.56-83.27%

Quantum Cyber Corporate Events

Business Operations and StrategyExecutive/Board Changes

Quantum Cyber Announces Board and Leadership Transition

Positive
Oct 16, 2026

Effective October 12, 2026, Quantum Cyber N.V. appointed retired Major General Alberto C. Rosende to its Board of Directors to fill a vacancy, naming him to the audit, compensation and nomination committees and confirming his status as an independent...

Business Operations and StrategyPrivate Placements and FinancingRegulatory Filings and Compliance

Quantum Cyber Launches $100 Million ATM Equity Program

Positive
Oct 9, 2026

On October 9, 2026, Quantum Cyber N.V. entered into a sales agreement with Titan Partners Securities LLC to launch an at-the-market equity offering of up to $100 million of its ordinary shares under an existing SEC shelf registration. The program all...

Business Operations and StrategyProduct-Related Announcements

Quantum Cyber Sharpens Defense Focus with New U.S. Hub

Positive
Sep 25, 2026

On September 25, 2026, Quantum Cyber announced a sharpened strategic focus built around three core pillars: its exclusively licensed quantum antenna for GPS-independent navigation and communications, one-way attack and interceptor drones, and the MAH...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 16, 2026